Connecting Midwest High Tech Startups With India MRUN Conf - Oct 12, 2012 Presentation by - Dinesh Jain, Founder CEO, Aagami Inc.

1. Connecting Midwest High Tech
Startups With India
MRUN Conf - Oct 12, 2012
Dinesh Jain, Founder CEO
Aagami, Inc.
…LifeSciences Catalyst

2. Topics covered
 India – an Introduction
 IN Lifesciences Industry snapshot
 Major centers of Lifesciences in India
 Major Deals and Investments showing
 India as a Market Place
 India as a Resource Place
 What Indian LS firms are looking for
 How Aagami Supports Companies
Lifesciences Catalyst 2

3. India – a Brief Introduction (V-IMP)
Nation of 1.22 Billion people (~EU+Africa)
 28 States and 7 Union Territories
 22 Official languages – English is widespread
Ancient Civilization – Young Nation
 Most Heterogeneous and complex
 Very Traditional Yet quite Modern
 Last 20 years GDP CAGR at ~7%
3rd Largest economy of the world in PPP (IMF)
 Sizeable # of Rich, yet average person very poor
 Sci, Tech and Business excel, poor Infrastructure
Lifesciences Catalyst 3

4. Indian LS Industry Snapshot
 3rd Largest Pharma market (by volume)
 LS Market ~ $25B, Healthcare ~ $65B
 Over 20,000 Pharma/BT companies
 Top 20 Companies have presence in Regulated
markets (US, Canada, Western EU and Japan)
 Top 100 companies are present in 50+ countries
 Globally successful in Generics
 “Every 3rd pill in the world is Made in India”
 Medicine Source of the developing world
 WHO sources over 70% from India
 Largest # of US FDA approved mfg facilities
Lifesciences Catalyst 4

5. Indian LS Industry Snapshot…cntd
Biotech Industry with exploding growth
Largest pool of Chemists and Biologists
Abundant specialty health institutions
 14000+ Hospitals, 700,000+ Beds
Large Pool of Medical professionals
 ~200 Medical Colleges graduating 30,000+ doctors per year
 600,000+ Doctors
 Largest pool of Biosciences Graduates Per
annum - 3 Million B.S., 700,000 M.S., 15000 Ph Ds
 Indian Regulation – a Super Set of US-FDA
All Technical & Business work in English
Lifesciences Catalyst 5

6. Major Centers of LS Business
City – Major Companies
Mumbai – Sun, Lupin,Wockhardt, Glenmark,
USV, Piramal, Ipca, Most MNCs
Ahmedabad – Zydus, Intas, Cadila, Torrent
 Hyderabad – Dr. Reddy’s, Aurobindo, Suven,
Divi’s, Hetero, Shantha, Bharat
 Bengaluru – Biocon, Micro, Strides, GSK,
 New Delhi – Ranbaxy, Panacea, Jubilant
 Chennai – Orchid, Shasun, Tablets India,
 Pune – Bilcare, Serum India, Advinus,
Lifesciences Catalyst 6

7. Major Centers of LS Research
City – Research Institutes
 New Delhi – ICPO, IGIB, TERI, ICGEB, IofPath, NIMS,
NIMR, NIPGR,
 Hyderabad – ICRISAT, CCMB, IICT, CDFD, ILS, LVP
Eye, NCLAS, NIN, ISB,
 Pune – NCL, Agarkar, Micobial Complex, NARI, NCCS,
NIV,
Mumbai – TIFR, BARC, Genetic RC, ICT,
Ahmedabad – NIPER, NIOH, NSD, IIM,
Bengaluru – IISc, NCBS, IBioInfoABio,
Kolkata – Guha CGEB, IICB, NICED,
Chennai – Biosys BT, CLRI, NIE, TBRC,
Nagpur – ICAR, CI Cotton R, NEERI, NIIPM, NRCC
Lucknow – CDRI, CI Med & A Plants, IIToxR, NBRI,
Lifesciences Catalyst 7

8. Major Intl Deals and Investments
 Wockhardt – Morton Grove, IL
 Sun – Caraco, MI, & Taro Israel
 Dr. Reddy’s – BetaPharm, DowPharma, BASF
 Lupin – Kyowa, Japan
 Piramal – Design Resource Group, MA
 DaiIchi Sankyo – Ranbaxy
 Abbott – Piramal Pharma (Shifting generic mfg)
 Sanofi – Shantha Biotech
 GSK – Large R&D center
 Fresinius Kabi – Large Development Center
 Merck, Estellas, Takeda, Biogen, Amgen, started
Lifesciences Catalyst 8

9. Latest Relevant News ….
 Oct 11 – Pharma industry creates 2nd most # of billionaires
 Oct 7 - India US announce Jt Research in BT
 Oct 5 – Takeda in $90 M Discovery deal with Advinus
 Sep 30 – DBT and ABLE roadmap for a $125B by 2025
Biotech industry from $4B in 2011
 Sep 14 – Piramal to launch own innovative drug in EU
 Sep 12 – Panacea forms JV with US’ Osmotica
 Jul 4 – Serum acquires Dutch firm Bithoven for $100M
 Jul 2 – AstraZeneca & Cellworks to design TB therapies
 Jun 20 – Novozymes & Praj to jtly develop Biofuels
 Jun 4 – Abbott sets Nutri research center with Biocon
 Apr 21 – Merck to set up $150M vaccine lab in Delhi
 Apr 16 – Piramal acquires Imaging R&D portfolio of Bayer
Lifesciences Catalyst 9

10. Indian Firms are looking for
Partnerships, Investment, Licensing or
Acquisitions of
Innovative compounds and technologies
Co-Development Opportunities
Novel Drug Delivery Systems
 Manufacturing in IN and the US
Companies in Regulated markets
Lifesciences Catalyst 10

11. Aagami Consulting Services offer
 In-Licensing or Out-Licensing
 Co-Development and Partnerships
 Mergers & Acquisitions
 Investments to and from India
 Finding the Right
 JV partners and/or Distributors
 CRO and CRAMS providers
 Contract Sales/Marketing companies
 Contract Manufacturing companies
Lifesciences Catalyst 11

12. Aagami brings
Extensive Operational Experience Globally
Deep Understanding of business and socio-
cultural differences in ways of working
Extensive network with top 100 Indian LS
companies at CXO levels
Deal experience with Western, Japanese and
Indian industry
Dedicated team with focus on Client success
Lifesciences Catalyst 12

13. Business Cultural Differences sample
Phrases and points in the US vs IN
•As Soon as Possible : ASAP vs ASAP
• Tomorrow : Next day vs In near future
• Will be done : surely be done vs will try best
• Business focus : Specialist vs Generalist
• Work driven by : Process vs Ad Hoc
• Everyday working : MBO vs MBC
• Business Xaction : Contractual vs Trust base
• Importance : Transaction vs Relationship
Confidential Lifesciences Catalyst 13

14. Sample List of Aagami Clients
USA International
 Dow - MI  Solvay - Belgium
 Aegis – CA  Delmar - Canada
 Advangene – IL  SOM Biotech - Spain
 MacuCLEAR – TX  Phosphagenics - Australia
 DesignMedix – OR  NanoSensing - Brazil
 Unitech Pharma – MI  Affitech - Denmark
 Loyola U Chicago – IL  Ilsan Ilvac - Turkey
 MW Univ. – IL, AZ  Pieris - Germany
 PLx - TX  Toppan – Japan
Lifesciences Catalyst 14

15. Our Approach
 Prepare ‘Elevator Pitch’ on client technology and/or company
customized to Specific business culture for e.g. India, Japan
 Identify Relevant Companies from our Database and resources
 Broadcast EP to Relevant Companies by email
 Follow-up with phone calls and emails with all
 Coordinate CDAs with interested Companies, and supply further
info thru emails and conference calls
 Organize a road show to India along with client representative/s
 Take appointments with right executives in interested companies
 Coordinate the logistics of the road show (v imp)
 Support in structuring and negotiations for finalizing the deal(s)
Lifesciences Catalyst 15

16. Realizing Possibilities with
Aagami, Inc.
2020 Calamos Ct, Suite 209
Naperville, IL 60564
Phone: (630) 799-1572
dinesh@aagami.net
www.aagami.net
Lifesciences Catalyst 16